Who are the key players in the Dengvaxia Market Report 2026 market?

Major companies operating in the Dengvaxia Market Report 2026 market are Major companies operating in the dengvaxia market are Sanofi Pasteur Inc. Read More

What are the major opportunities in the Dengvaxia market? What are the strategies for the Dengvaxia market?

For detailed insights on the major opportunities and strategies in the Dengvaxia market, Read More

How does the Dengvaxia market relate to the overall economy and other similar markets?

For detailed insights on Dengvaxia's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Dengvaxia industry?

For detailed insights on the mergers and acquisitions in the Dengvaxia industry, Read More

What are the key dynamics influencing the Dengvaxia market growth? SWOT analysis of the Dengvaxia market.

For detailed insights on the key dynamics influencing the Dengvaxia market growth and SWOT analysis of the Dengvaxia industry, Read More

Dengvaxia Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Dengvaxia Market Report 2026

Name: Dengvaxia Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Dengvaxia Market Overview

• The Dengvaxia market growth in the historic period has been driven by recurring dengue outbreaks, high disease burden in tropical regions

• Market expansion is supported by expansion of vaccination coverage, increasing climate driven mosquito spread

• Growth Driver: Rising Dengue Incidence Drives Growth In The Market

• Asia-Pacific was the largest region in 2025 and Latin America is the fastest growing region.

What Is Covered Under Dengvaxia Market?

Dengvaxia is a recombinant vaccine developed to protect against dengue fever, a viral illness transmitted by Aedes mosquitoes, by stimulating the immune system to produce a targeted response that helps prevent infection and severe complications, contributing to public health efforts in regions where dengue is endemic.

The main types of dengvaxia are dengvaxia and others. Dengvaxia is a specific vaccine developed to prevent dengue fever. It is the first dengue vaccine approved for use and is designed to provide immunity against the virus that causes dengue. It helps reduce the severity and frequency of dengue episodes, making it an important tool in areas prone to dengue outbreaks. Dengvaxia has been used in various countries where dengue is prevalent to protect high-risk populations. These are distributed through hospitals, clinics, and public health programs and are used in multiple clinical indications such as prevention in previously infected individuals, protection in high-risk regions, traveler immunization, and pediatric and adolescent use.

Dengvaxia Market Global Report 2026 Market Report bar graph

What Is The Dengvaxia Market Size and Share 2026?

The dengvaxia market size has grown rapidly in recent years. It will grow from $213.36 million in 2025 to $250.81 million in 2026 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to recurring dengue outbreaks, high disease burden in tropical regions, government led immunization initiatives, limited treatment options for dengue, rising public health awareness.

What Is The Dengvaxia Market Growth Forecast?

The dengvaxia market size is expected to see rapid growth in the next few years. It will grow to $473.95 million in 2030 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to expansion of vaccination coverage, increasing climate driven mosquito spread, growth in public health funding, improved vaccine delivery infrastructure, rising travel related immunization demand. Major trends in the forecast period include expansion of dengue vaccination programs, growing focus on endemic disease prevention, rising public health immunization campaigns, increased surveillance of mosquito-borne diseases, strengthening of pediatric and adolescent vaccination.

Book your 30 minutes free consultation with our research experts

Global Dengvaxia Market Segmentation

1) By Type: Dengvaxia, Other Types

2) By Distribution Channel: Hospitals, Clinics, Public Health Programs

3) By Clinical Indication: Prevention In Previously Infected Individuals, Protection In High-Risk Regions, Traveler Immunization, Pediatric And Adolescent Use

What Are The Drivers Of The Dengvaxia Market?

The high incidence of dengue is expected to propel the growth of the dengvaxia market going forward. Dengue is a viral infection transmitted by Aedes mosquitoes, causing flu-like symptoms, severe pain, and in severe cases, potentially life-threatening complications such as dengue hemorrhagic fever or dengue shock syndrome. The increasing prevalence of dengue is due to climate change, urbanization, increased travel, and expanding mosquito breeding grounds, leading to higher infection rates and greater demand for prevention and treatment. Dengvaxia helps prevent dengue as it is an effective vaccine that stimulates the immune system to produce a protective response against the dengue virus, reducing the risk of infection and severe complications and contributing to better public health outcomes in endemic areas. For instance, in June 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, the Americas reported over 9.7 million dengue cases, double the 4.6 million cases in 2023. Puerto Rico declared a public health emergency with 1,498 cases, and 745 cases were reported among U.S. travelers. Therefore, the high incidence of dengue is driving growth in the dengvaxia industry.

Rising international travel is expected to propel the growth of the dengvaxia market going forward. International travel refers to the act of traveling between different countries for purposes such as tourism, business, or education. Rising international travel increases the risk of spreading infectious diseases, including dengue, which drives the demand for preventive measures like vaccines. Dengvaxia is used in rising international travel to protect travelers from contracting dengue in endemic regions and reduce the risk of disease transmission across borders. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, in 2023, the number of international visits to the UK saw a significant increase, rising from 31.2 million in 2022 to 38.0 million. Therefore, rising international travel will drive the growth of the dengvaxia industry.

Growing healthcare expenditures are expected to accelerate the growth of the dengvaxia market going forward. Healthcare expenditures refer to the financial resources allocated by governments, private entities, or individuals for the provision of healthcare services, medical treatments, and health-related activities. Growth in healthcare expenditures is driven by the increasing demand for medical services, advancements in healthcare technology, and the rising prevalence of chronic diseases, which leads to greater investment in healthcare infrastructure and treatments. Healthcare expenditure on Dengvaxia focuses on prevention, aiming to reduce the long-term costs of treating dengue and managing outbreaks. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms from 2022 to 2023, marking a significant acceleration compared to the 0.9% growth observed in 2022. Therefore, growing healthcare expenditures will drive the growth of the dengvaxia industry.

Key Players In The Global Dengvaxia Market

Major companies operating in the dengvaxia market are Sanofi Pasteur Inc.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

Asia-Pacific was the largest region in the dengvaxia market in 2025. Latin America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Dengvaxia Market?

The dengvaxia market consists of sales of dengvaxia (CYD-TDV), disposable syringes and needles, pre-filled syringes of dengvaxia, and unit-dose packaging. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Dengvaxia Market Report 2026?

The dengvaxia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the dengvaxia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Dengvaxia Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	CAGR of 17.6% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Distribution Channel, Clinical Indication
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Sanofi Pasteur Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Dengvaxia Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Dengvaxia Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Dengvaxia Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Dengvaxia Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Sustainability, Climate Tech & Circular Economy

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Expansion Of Dengue Vaccination Programs

4.2.2 Growing Focus On Endemic Disease Prevention

4.2.3 Rising Public Health Immunization Campaigns

4.2.4 Increased Surveillance Of Mosquito-Borne Diseases

4.2.5 Strengthening Of Pediatric And Adolescent Vaccination

5. Dengvaxia Market Analysis Of End Use Industries

5.1 Public Health Programs

5.2 Hospitals

5.3 Clinics

5.4 Travel Medicine Centers

5.5 Pediatric Healthcare Centers

6. Dengvaxia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Dengvaxia Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Dengvaxia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Dengvaxia Market Size, Comparisons And Growth Rate Analysis

7.3. Global Dengvaxia Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Dengvaxia Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Dengvaxia Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Dengvaxia Market Segmentation

9.1. Global Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dengvaxia, Other Types

9.2. Global Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Public Health Programs

9.3. Global Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prevention In Previously Infected Individuals, Protection In High-Risk Regions, Traveler Immunization, Pediatric And Adolescent Use

10. Dengvaxia Market Regional And Country Analysis

10.1. Global Dengvaxia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Dengvaxia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Dengvaxia Market

11.1. Asia-Pacific Dengvaxia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Dengvaxia Market

12.1. China Dengvaxia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Dengvaxia Market

13.1. India Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Dengvaxia Market

14.1. Japan Dengvaxia Market Overview

14.2. Japan Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Dengvaxia Market

15.1. Australia Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Dengvaxia Market

16.1. South Korea Dengvaxia Market Overview

16.2. South Korea Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Dengvaxia Market

17.1. Western Europe Dengvaxia Market Overview

17.2. Western Europe Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Dengvaxia Market

18.1. UK Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Dengvaxia Market

19.1. Germany Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Dengvaxia Market

20.1. France Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Dengvaxia Market

21.1. Eastern Europe Dengvaxia Market Overview

21.2. Eastern Europe Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Dengvaxia Market

22.1. North America Dengvaxia Market Overview

22.2. North America Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Dengvaxia Market

23.1. USA Dengvaxia Market Overview

23.2. USA Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Dengvaxia Market

24.1. Canada Dengvaxia Market Overview

24.2. Canada Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Dengvaxia Market

25.1. South America Dengvaxia Market Overview

25.2. South America Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Dengvaxia Market

26.1. Middle East Dengvaxia Market Overview

26.2. Middle East Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Dengvaxia Market

27.1. Africa Dengvaxia Market Overview

27.2. Africa Dengvaxia Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Dengvaxia Market Regulatory and Investment Landscape

29. Dengvaxia Market Competitive Landscape And Company Profiles

29.1. Dengvaxia Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Dengvaxia Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Dengvaxia Market Company Profiles

29.3.1. Sanofi Pasteur Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Dengvaxia Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Dengvaxia Market

32. Dengvaxia Market High Potential Countries, Segments and Strategies

32.1 Dengvaxia Market In 2030 - Countries Offering Most New Opportunities

32.2 Dengvaxia Market In 2030 - Segments Offering Most New Opportunities

32.3 Dengvaxia Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Dengvaxia Market, Overview Of Key Products - Product Examples

Table 2: Global Dengvaxia Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Dengvaxia Market, Supply Chain Analysis

Table 4: Global Dengvaxia Market, Major Raw Material Providers

Table 5: Global Dengvaxia Market, Major Resource Providers

Table 6: Global Dengvaxia Market, Major Manufacturers (Suppliers)

Table 7: Global Dengvaxia Market, Major Distributors And Channel Partners

Table 8: Global Dengvaxia Market, Key Technologies & Future Trends

Table 9: Global Dengvaxia Market, Major Trends

Table 10: Global Dengvaxia Market, Major End Users

Table 11: Global Dengvaxia Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Dengvaxia Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Dengvaxia Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Dengvaxia Market - TAM, US$ Billion, 2025

Table 15: Global Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Dengvaxia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Dengvaxia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: South Korea, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: South Korea, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Western Europe, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Western Europe, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: UK, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: UK, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Germany, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Germany, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: France, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: France, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Eastern Europe, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Eastern Europe, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: North America, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: North America, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: USA, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: USA, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Canada, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Canada, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: South America, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: South America, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Middle East, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Middle East, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Africa, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Africa, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Global Dengvaxia Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 72: Global Dengvaxia Market - Company Scoring Matrix

Table 73: Sanofi Pasteur Inc. Financial Performance

Table 74: Global Dengvaxia Market, Competitive Benchmarking (In USD Billions)

Table 75: Global Dengvaxia Market, Competitive Dashboard

Table 76: Global Dengvaxia Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 77: Global, Dengvaxia Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 78: Global, Dengvaxia Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Table 79: Global, Dengvaxia Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030

List Of Figures

Figure 1: Global Dengvaxia Market, Overview Of Key Products - Product Examples

Figure 2: Global Dengvaxia Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Dengvaxia Market, Supply Chain Analysis

Figure 4: Global Dengvaxia Market, Major Raw Material Providers

Figure 5: Global Dengvaxia Market, Major Resource Providers

Figure 6: Global Dengvaxia Market, Major Manufacturers (Suppliers)

Figure 7: Global Dengvaxia Market, Major Distributors And Channel Partners

Figure 8: Global Dengvaxia Market, Key Technologies & Future Trends

Figure 9: Global Dengvaxia Market, Major Trends

Figure 10: Global Dengvaxia Market, Major End Users

Figure 11: Global Dengvaxia Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Dengvaxia Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Dengvaxia Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Dengvaxia Market - TAM, US$ Billion, 2025

Figure 15: Global Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Dengvaxia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Dengvaxia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: South Korea, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: South Korea, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Western Europe, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Western Europe, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: UK, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: UK, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Germany, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Germany, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: France, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: France, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Eastern Europe, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Eastern Europe, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: North America, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: North America, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: USA, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: USA, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Canada, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Canada, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: South America, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: South America, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Middle East, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Middle East, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Africa, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Africa, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Global Dengvaxia Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 72: Global Dengvaxia Market - Company Scoring Matrix

Figure 73: Sanofi Pasteur Inc. Financial Performance

Figure 74: Global Dengvaxia Market, Competitive Benchmarking (In USD Billions)

Figure 75: Global Dengvaxia Market, Competitive Dashboard

Figure 76: Global Dengvaxia Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 77: Global, Dengvaxia Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 78: Global, Dengvaxia Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Figure 79: Global, Dengvaxia Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Vaccine Contract Manufacturing Market Report 2026 - Global Outlook – By Service Type (Fill-Finish, Bulk Product), By Vaccine Type (Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit ...

Malaria Treatment Market Report 2026 - Global Outlook – By Treatment (Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments), By Route Of Administration (Oral, Parenteral, Intravenous), By Distribution C...

Infectious Disease Therapeutics Market Report 2026 - Global Outlook – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharm...

Rare Diseases Treatment Market Report 2026 - Global Outlook – By Drug Type (Originator Drugs (Patented Molecules), Generic Drugs), By Drug Class (Biologics, Organic Compounds), By Mode Of Administration (Injectable, Oral...

Avian Flu Treatment Market Report 2026 - Global Outlook – By Type (Vaccines, Antiviral Agents, Immunoglobulins), By Distribution Channel (Online Pharmacies, Offline Pharmacies), By End User (Hospital, Institutional Healt...

Chickenpox Vaccine Market Report 2026 - Global Outlook – By Vaccine (Monovalent Varicella Vaccine, Combination Varicella Vaccine), By Application (Mumps, Measles, Rubella, And Varicella Immunization, Herpes Zoster Immuni...

Malaria Vaccines Market Report 2026 - Global Outlook – By Agent (Plasmodium Falciparum, Plasmodium Vivax), By Vaccine Type (Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines), By Route Of Administration (Intr...

Frequently Asked Questions

How big is the Dengvaxia Market?

The Dengvaxia market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

What is the Dengvaxia market growth?

The global Dengvaxia market is expected to grow at a CAGR of 17.2% from 2026 to 2035 to reach $ billion by 2035.

Who are the key players in Dengvaxia market?

Some Key Players in the Dengvaxia market Include, Sanofi Pasteur Inc. .

What is the anticipated growth trend for the Dengvaxia market?

Major trend in this market includes: nan. For further insights on this market. request a sample here

Which region has the most growth potential in the Dengvaxia market?

Asia-Pacific was the largest region in the dengvaxia market in 2025. Latin America is expected to be the fastest-growing region in the forecast period. The regions covered in the dengvaxia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.